Clinical Trials in Atlanta

Showing 3801-3820 of 9,468 trials

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

NCT04886388

BT-001 is a software program intended to help patients with type 2 diabetes, under the guidance of their physician, improve glycemic control (i.e., levels of blood sugar). The BT-001 software delivers a type of behavioral therapy to patients via a mobile application that targets behaviors related to achieving glycemic control. The effectiveness of BT-001 will be measured by its ability to help patients reduce Hemoglobin A1c, or HbA1c (a marker in the blood that measures blood sugar) compared to standard medical care in patients with type 2 diabetes.

Type 2 Diabetes

Better Therapeutics668 participantsStarted Apr 2021

San Francisco, California, United States • Miami, Florida, United States • Atlanta, Georgia, United States +3 more locations

COMPLETEDNA< 1 mile

Correlation Between Montreal Cognitive Assessment and Voice Therapy Outcomes in the Aging Treatment- Seeking Population

NCT05187910

This study will investigate if the performance on the Montreal Cognitive Assessment (MoCA) is associated or predictive of the outcomes in voice, swallowing or upper airway therapy in the older laryngology treatment seeking patients. The relationship between the scores of MoCA and parameters in therapy will be analyzed. The outcomes of this study could potentially impact how investigators determine candidacy for therapy and develop patient treatment plans to meet their needs. This is a collaborative study with Emory Voice Center and the NYU Voice Center.

Cognitive ImpairmentVoice DisordersVoicebox Disorders+2 more

University of California, San Francisco57 participantsStarted Mar 2021

San Francisco, California, United States • Atlanta, Georgia, United States • New York, New York, United States +1 more locations

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

Correlation Between Montreal Cognitive Assessment and Voice Therapy Outcomes in the Aging Treatment- Seeking Population

Find Trials by Condition in Atlanta

Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

Safety Study of Femoral Neck Fracture System

Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-Small Cell Lung Cancer (NSCLC) (MK-3475-598/KEYNOTE-598)

Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer

Development of the Virtual Unified Huntington's Disease Rating Scale

Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD

Human Epilepsy Project 2: Resistant Focal Seizures Study

A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer

A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination

Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Negative for Hepatitis B e Antigen

Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients

Bioaerosol Sampling Device (BSD) Clinical Study

Multi-Center Pilot Study of truSculpt Device

MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram

Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity